FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 […]

Continue Reading

AHA News: While Mopping, Young Mom’s Heart Tore

FRIDAY, April 16, 2021 (American Heart Association News) — On a Saturday morning last August, Sindi Mafu had started her typical weekly chores – dusting, laundry, sweeping. Her 4-year-old daughter, Avela, was busy with her Zoom ballet class, and her toddler, Lunga, was eating his breakfast. Sindi grabbed her mop. She started sweating – profusely. […]

Continue Reading

4 in 10 Transgender Women Have HIV: CDC

FRIDAY, April 16, 2021 — Four in 10 transgender women have HIV, which shows the urgent need to offer them more prevention and treatment services, according to a new U.S. Centers for Disease Control and Prevention report. In interviews with more than 1,600 transgender women in Atlanta, Los Angeles, New Orleans, New York City, Philadelphia, […]

Continue Reading

Amgen successfully completes acquisition of Five Prime Therapeutics

Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics (NASDAQ:FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, for $38.00 per share in cash. The aggregate consideration to be paid by Amgen to complete […]

Continue Reading